Details

Autor(en) / Beteiligte

• Ezzikouri, Sayeh
• Jadid, Fatima Zahra
• Hamdi, Salsabil
• Wakrim, Lahcen
• Tsukiyama-Kohara, Kyoko
• Benjelloun, Soumaya

Titel

Supplementing Conventional Treatment with Pycnogenol® May Improve Hepatitis C Virus-Associated Type 2 Diabetes: A Mini Review

Ist Teil von

• Journal of clinical and translational hepatology, 2016-09, Vol.4 (3), p.228-233

Ort / Verlag

China: Virology Unit, Viral Hepatitis Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco%Virology Unit, Immunovirology Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco%Laboratory of Animal Hygiene, Joint Faculty of Veterinary Medicine,Kagoshima University, Kagoshima, Japan

Erscheinungsjahr

2016

Quelle

EZB Electronic Journals Library

Beschreibungen/Notizen

• Hepatitis C virus (HCV) infection and type 2 diabetes mellitus (T2DM) present a significant health burden, with increasing complications and mortality rates worldwide. Pycnogenol® (PYC), a natural product, possesses antidiabetic and antiviral properties that may improve HCV-associated T2DM. In this review, we present previously published data on the effectiveness of PYC against HCV replication and T2DM. We believe that supplementing conventional treatment with PYC may improve the current HCV therapy, attenuate HCV-associated T2DM, and reduce the risk of complications such as cirrhosis or hepatocellular carcinoma and cardiovascular disease.